The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

NCT07507513 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: 627
DRUG: Placebo

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.